Healthy Living/WellnessFDA Gives Nod Of Approval To Roche Hemophilia Drug Roche’s hemophilia drug is being expedited in development after receiving breakthrough therapy designation from the FDA, addressing an unmet need for patients of the genetic disorder.by Dianne Depra
Healthy Living/WellnessRoche Purchases GeneWEAVE Diagnostics Firm In $425 Million Dealby Rina Marie Doctor
Healthy Living/WellnessFDA Gives Roche Breakthrough Therapy Designation For Venetoclax CLL Treatmentby Sumit Passary
Healthy Living/WellnessNew Study Indicates Roche-Made Tamiflu Beneficial Against Influenzaby Sumit Passary
Healthy Living/WellnessDouble Blow: Roche Drugs for Breast Cancer and Alzheimer's Fail in Trialsby Rhodi Lee
Healthy Living/WellnessGenentech Submits New Drug Application for Cobimetinib with Zelboraf for Treating Advanced Melanomaby Dianne Depra
Healthy Living/WellnessFDA Approves Avastin Use for Ovarian Cancer Resistant to Platinum-containing Chemotherapyby Dianne Depra
Healthy Living/WellnessPerjeta may boost survival for advanced breast cancer patientsby James Maynard
Healthy Living/WellnessRoche breast cancer drug Perjeta helped extend patients' lives by over a year in clinical trialby Rhodi Lee
Healthy Living/WellnessRoche Group's Avastin for cervical cancer given priority review status by FDAby Dianne Depra
Healthy Living/WellnessSkin cancer drug by Roche meets goals during late-stage testingby Dianne Depra